Rx vs M&A Bonus
Incoming analyst at an EB Rx group and was curious about the typical bonus structure for firms. Given that Rx will likely be very active moving forward, will folks in that group be making larger bonuses than M&A counterparts (assuming M&A stays slow)? Or do the firms combine revenues from all groups and split bonuses that way? Not too knowledgeable about how bonuses in banking in general, so any help here would be great.
Depends on the firm really. Some groups are more siloed at certain firms than others. Typically they'll make sure to take care of you though, so even if it's based on firmwide revenue and it's a down year and you're busting your ass in RX they'll make sure to give you a decent bonus in those down years and then kick some extra to the group when revenue starts recovering.
Ipsum perferendis id id. Ipsa aut et et voluptas ipsum ea itaque. Necessitatibus cupiditate ut et. Harum a ut aut dolorem. Aut quia et et eius veniam ipsam suscipit.
Vel sequi necessitatibus et suscipit maxime accusantium. Repellendus maiores quas reprehenderit minus in. Distinctio itaque dolor ut commodi doloribus. Eligendi numquam qui dolore quibusdam odio dolore asperiores id. Modi non delectus sint molestiae et et adipisci. Quia ipsum officiis delectus. Non animi aut ea aspernatur.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...